The design and trial of conjugates for performing lanthanide immunofluorescence analysis
Sokolova, M.V.; Pomelova, V.G.; Chudinov, A.V.; Gaĭdamovich, S.I.; Leonov, S.V.; Kharitonenkov, I.G.; Bychenkova, T.A.; Busel, E.P.; Zlobin, V.N.
Voprosy Virusologii 36(2): 140-142
1991
ISSN/ISBN: 0507-4088 PMID: 1715628 Document Number: 387688
The possibility of using a number of complexons for labeling of antibodies to Venezuelan equine encephalomyelitis virus and to adenovirus with europium ions was studied. The resultant conjugates, irrespective of the type of complexon, were shown to retain their immunochemical activity and could be used for lanthanide immunofluorescence analysis of virus-specific antigens.
Document emailed within 1 workday
Related Documents
Kharitonenkov, I.G.; Khalonen, P.; Khristova, M.L.; Kivivirta, M.; Busse, T.L.; Sokolova, M.V. 1989: Stat-diagnosis of influenza using lanthanide immunofluorescence analysis Voprosy Virusologii 34(5): 533-538Busse, T.L.; Khalling, T.A.; Khristova, M.L.; Allikmets, E.U.; Kharitonenkov, I.G.; Saarma, M.J.; Halonen, P. 1991: The strain-specific diagnosis of influenza by using lanthanide immunofluorescence analysis based on monoclonal antibodies to the hemagglutinin of the influenza a virus Voprosy Virusologii 36(4): 290-293
Kharitonenkov, I.G.; Gaĭdamovich, S.I.; Pomelova, V.G.; Sokolova, M.V.; Lavrova, N.A.; Leonov, S.V.; Zlobin, V.N. 1990: A rapid isolation of Venezuelan equine encephalomyelitis virus using the lanthanide immunofluorescence assay Voprosy Virusologii 35(1): 77-79
Pomelova, V.G.; Zavodchikova, E.N.; Lavrova, N.A.; Kovalenko, V.A.; Gaĭdamovich, S.I. 1992: The effectiveness of lanthanide immunofluorescence and immunoenzyme analyses in differentiating viruses of the tick-borne encephalitis complex Voprosy Virusologii 37(5-6): 244-247
Wohlzogen, F.X. 1970: Design and analysis of a clinical trial of antihypertensives Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(1): 157-160
Fournier, J.; Dodin, A. 1971: Antigenic similarities of Whitman bacillus and glanders bacillus. Trial analysis by immunofluorescence Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 64(6): 832-836
Wang, Y.-j.; Cao, X.; Liu, X.-y.; Lu, X.-l.; Li, Y.-y.; Jiao, B.-h. 2016: Antibody-drug conjugates: design and clinical progress Yao Xue Xue Bao 51(8): 1209-1216
Waters, E.; Priest, P.; Foster, C.; Andermann, A. 1999: Preventing injuries in children. Elements of trial's design and analysis might have biased results Bmj 319(7209): 574-575
Veldhuyzen van Zanten, S.J.; Cleary, C.; Talley, N.J.; Peterson, T.C.; Nyrén, O.; Bradley, L.A.; Verlinden, M.; Tytgat, G.N. 1996: Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials American Journal of Gastroenterology 91(4): 660-673
Reddy, B.S.; Damayanthi, Y.; Reddy, B.S.; Lown, J.W. 2000: Design, synthesis and in vitro cytotoxicity studies of novel pyrrolo[2,1-c][1,4]benzodiazepine (PBD)--polymade conjugates and 2,2'-PBD dimers Anti-Cancer Drug Design 15(3): 225-238
Wainer, I.W.; Schneider, L.C.; Weber, J.D. 1981: Application of chiral lanthanide nuclear magnetic resonance shift reagents to pharmaceutical analysis. II. Determination of dextro- and levoamphetamine mixtures Journal - Association of Official Analytical Chemists 64(4): 848-850
Kramer, M.S.; Chalmers, B.; Hodnett, E.D.; Sevkovskaya, Z.; Dzikovich, I.; Shapiro, S.; Collet, J.P.; Vanilovich, I.; Mezen, I.; Ducruet, T.; Shishko, G.; Zubovich, V.; Mknuik, D.; Gluchanina, E.; Dombrovsky, V.; Ustinovitch, A.; Ko, T.; Bogdanovich, N.; Ovchinikova, L.; Helsing, E. 2000: Promotion of breastfeeding intervention trial (PROBIT): a cluster-randomized trial in the Republic of Belarus. Design, follow-up, and data validation Advances in Experimental Medicine and Biology 478: 327-345
Lindsey, J.C.; Shah, S.K.; Siberry, G.K.; Jean-Philippe, P.; Levin, M.J. 2013: Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings Developing World Bioethics 13(2): 95-104
Maciá Martínez, M.A.; Cuena Boy, R.; Solera Santos, J. 1997: Experience in performing a clinical trial not promoted by the pharmaceutical industry Medicina Clinica 108(8): 314-315
Oggero, E.; Pagnacco, G.; Berme, N.; Kinzel, G.L.; Luscher, A.F. 2001: Force transducer design: a new approach combining nonlinear finite element analysis and robust design Biomedical Sciences Instrumentation 37: 49-54
Wagner, G.; Oehlke, J. 1977: Mercaptopurine-protein-azoconjugates. 2. Acid and light sensitive structures in the conjugates. 13. Immunosuppressive agent-antigen conjugates Die Pharmazie 32(3): 157-162
Lin, P.-H.; Intille, S.; Bennett, G.; Bosworth, H.B.; Corsino, L.; Voils, C.; Grambow, S.; Lazenka, T.; Batch, B.C.; Tyson, C.; Svetkey, L.P. 2015: Adaptive intervention design in mobile health: Intervention design and development in the Cell Phone Intervention for you trial Clinical Trials 12(6): 634-645
Lapierre, J.; Floch, H.A.; Holler, C.; Saison, E. 1972: Distribution of intestinal schistosomiasis in Guadeloupe: sero-immunologic survey by immunofluorescence (1st trial) Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 65(3): 434-437
Sauer, H.; Ambrosius, H. 1978: Manipulations of immune reactions by antigen-immunosuppressive agent-conjugates. VI. Antigen specific binding of 6-mercaptopurine-protein conjugates by lymphocytes Acta Biologica et Medica Germanica 37(7): 1099-1103
Hayes, R.; Ayles, H.; Beyers, N.; Sabapathy, K.; Floyd, S.; Shanaube, K.; Bock, P.; Griffith, S.; Moore, A.; Watson-Jones, D.; Fraser, C.; Vermund, S.H.; Fidler, S. 2014: HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial Trials 15: 57